Position in ADCT
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$1,834,045
+$168,970 QoQ
Shares Held
489,079
+3.7% QoQ
Ownership
0.385%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
21 quarters on record
Voting authority
Sole 91%
Shared 0%
None 9%
Common Shares in ADCT Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026JPMORGAN CHASE & CO holds $2,053,485,768 across 61 Drug Manufacturers - Specialty & Generic names. ADCT ranks #30 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
5,442,067 | $716,937,900 | |
| 2 | ZTS |
Zoetis Inc.
|
3,387,174 | $400,397,831 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
6,762,744 | $203,693,847 | |
| 4 | ALKS |
Alkermes plc.
|
4,101,789 | $145,039,257 | |
| 5 | HIMS |
Hims & Hers Health, Inc.
|
5,240,816 | $108,799,337 | |
| 6 | HLN |
Haleon plc
|
8,279,468 | $82,877,469 | |
| 7 | VTRS |
Viatris Inc
|
5,731,565 | $77,433,437 | |
| 8 | RDY |
Dr Reddys Laboratories Ltd
|
4,371,378 | $60,543,580 |
All Filings in ADCT
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,834,045 | 489,079 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $1,665,075 | 471,693 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $1,322,388 | 330,597 | Shares | Defined | 2025-11-26 | |
| 2025-06-30 | $91,781 | 34,247 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $56,003 | 39,719 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $73,671 | 37,021 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $248,259 | 78,813 | Shares | Defined | 2024-12-26 | |
| 2024-06-30 | $94,284 | 29,837 | Shares | Defined | 2024-12-26 | |
| 2023-06-30 | $5,934,173 | 2,760,081 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $6,029,036 | 3,091,814 | Shares | Defined | 2023-05-18 | |
| 2022-12-31 | $11,537,147 | 3,004,466 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $16,467,610 | 3,416,517 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $27,456,692 | 3,453,672 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $50,160,913 | 3,414,630 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $64,535,806 | 3,194,842 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $88,758,498 | 3,267,986 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $77,876,363 | 3,198,208 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $76,702,395 | 3,142,253 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $95,611,244 | 2,986,918 | Shares | Defined | 2021-02-19 | |
| 2020-09-30 | $68,893,412 | 2,088,312 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $53,493,203 | 1,142,773 | Shares | Defined | 2020-08-11 | |
| No filing history on record for this holder in this stock. | ||||||